GALAXYSURF Galaxy Surfactants Q3 FY26 results (Oct–Dec 2025) and concall
Galaxy Surfactants navigated a challenging Q3 FY26 marked by reformulation pressures in India and a significant volume decline in AMET. Despite these headwinds, the company achieved a 13% YoY growth in Q3 EBITDA before exceptional items, driven by strong specialty segment performance and improved contribution realization. A key positive development was the reduction of U.S. tariffs on Indian exports, expected to boost future growth, while new product commercialization is set to begin in Q4 FY26.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q3 FY26: revenue up 27.5%, net profit down 9.2% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 1,063 | 1,042 | 1,145 | 1,278 | 1,326 +25% | 1,329 +28% |
| EBITDA | 128 | 106 | 127 | 124 | 110 −14% | 119 +12% |
| Net profit | 85 | 65 | 76 | 79 | 66 −22% | 59 −9% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
